In vivo grafting of large, engineered heart tissue patches for cardiac repair

As the prevalence of heart failure continues to climb worldwide, most treatments that are currently available work by slowing down disease progression rather than actively reversing the disease process1. Therefore, novel therapies are urgently needed, specifically for the aging population. In recent years, clinical trials in cardiac cell therapy have shown some promise however,